Global Hemostats Market Research Report 2023(Status and Outlook)

Global Hemostats Market Research Report 2023(Status and Outlook)



Report Overview

Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.

Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.

North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.

In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.

The Global Hemostats Market Size was estimated at USD 2592.50 million in 2022 and is projected to reach USD 3872.49 million by 2029, exhibiting a CAGR of 0.06 during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Hemostats market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hemostats Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hemostats market in any manner.

Global Hemostats Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Ethicon

Pfizer

Baxter International Inc.

C. R. Bard

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Integra LifeSciences Corporation

B Braun Melsungen AG

Gelita Medical GmbH

Equimedical

Vascular Solutions

Marine Polymer Technologies

Z-Medica, LLC

CryoLife

BioCer Entwicklungs-GmbH.

Biom'Up SAS

Market Segmentation (by Type)

Thrombin-Based Hemostats

Oxidized Regenerated Cellulose Based Hemostats

Combination Hemostats

Gelatin Based Hemostats

Collagen Based Hemostats

Market Segmentation (by Application)

Consumer Electronics

Automotive

Home Appliance

IT & Telecommunication

Medical Equipment

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Hemostats Market

Overview of the regional outlook of the Hemostats Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hemostats
1.2 Key Market Segments
1.2.1 Hemostats Segment by Type
1.2.2 Hemostats Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hemostats Market Overview
2.1 Global Market Overview
2.1.1 Global Hemostats Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Hemostats Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hemostats Market Competitive Landscape
3.1 Global Hemostats Sales by Manufacturers (2018-2023)
3.2 Global Hemostats Revenue Market Share by Manufacturers (2018-2023)
3.3 Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hemostats Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Hemostats Sales Sites, Area Served, Product Type
3.6 Hemostats Market Competitive Situation and Trends
3.6.1 Hemostats Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hemostats Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hemostats Industry Chain Analysis
4.1 Hemostats Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hemostats Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hemostats Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hemostats Sales Market Share by Type (2018-2023)
6.3 Global Hemostats Market Size Market Share by Type (2018-2023)
6.4 Global Hemostats Price by Type (2018-2023)
7 Hemostats Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hemostats Market Sales by Application (2018-2023)
7.3 Global Hemostats Market Size (M USD) by Application (2018-2023)
7.4 Global Hemostats Sales Growth Rate by Application (2018-2023)
8 Hemostats Market Segmentation by Region
8.1 Global Hemostats Sales by Region
8.1.1 Global Hemostats Sales by Region
8.1.2 Global Hemostats Sales Market Share by Region
8.2 North America
8.2.1 North America Hemostats Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hemostats Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hemostats Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hemostats Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hemostats Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Ethicon
9.1.1 Ethicon Hemostats Basic Information
9.1.2 Ethicon Hemostats Product Overview
9.1.3 Ethicon Hemostats Product Market Performance
9.1.4 Ethicon Business Overview
9.1.5 Ethicon Hemostats SWOT Analysis
9.1.6 Ethicon Recent Developments
9.2 Pfizer
9.2.1 Pfizer Hemostats Basic Information
9.2.2 Pfizer Hemostats Product Overview
9.2.3 Pfizer Hemostats Product Market Performance
9.2.4 Pfizer Business Overview
9.2.5 Pfizer Hemostats SWOT Analysis
9.2.6 Pfizer Recent Developments
9.3 Baxter International Inc.
9.3.1 Baxter International Inc. Hemostats Basic Information
9.3.2 Baxter International Inc. Hemostats Product Overview
9.3.3 Baxter International Inc. Hemostats Product Market Performance
9.3.4 Baxter International Inc. Business Overview
9.3.5 Baxter International Inc. Hemostats SWOT Analysis
9.3.6 Baxter International Inc. Recent Developments
9.4 C. R. Bard
9.4.1 C. R. Bard Hemostats Basic Information
9.4.2 C. R. Bard Hemostats Product Overview
9.4.3 C. R. Bard Hemostats Product Market Performance
9.4.4 C. R. Bard Business Overview
9.4.5 C. R. Bard Hemostats SWOT Analysis
9.4.6 C. R. Bard Recent Developments
9.5 The Medicines Company
9.5.1 The Medicines Company Hemostats Basic Information
9.5.2 The Medicines Company Hemostats Product Overview
9.5.3 The Medicines Company Hemostats Product Market Performance
9.5.4 The Medicines Company Business Overview
9.5.5 The Medicines Company Hemostats SWOT Analysis
9.5.6 The Medicines Company Recent Developments
9.6 Anika Therapeutics
9.6.1 Anika Therapeutics Hemostats Basic Information
9.6.2 Anika Therapeutics Hemostats Product Overview
9.6.3 Anika Therapeutics Hemostats Product Market Performance
9.6.4 Anika Therapeutics Business Overview
9.6.5 Anika Therapeutics Recent Developments
9.7 Advanced Medical Solutions
9.7.1 Advanced Medical Solutions Hemostats Basic Information
9.7.2 Advanced Medical Solutions Hemostats Product Overview
9.7.3 Advanced Medical Solutions Hemostats Product Market Performance
9.7.4 Advanced Medical Solutions Business Overview
9.7.5 Advanced Medical Solutions Recent Developments
9.8 Integra LifeSciences Corporation
9.8.1 Integra LifeSciences Corporation Hemostats Basic Information
9.8.2 Integra LifeSciences Corporation Hemostats Product Overview
9.8.3 Integra LifeSciences Corporation Hemostats Product Market Performance
9.8.4 Integra LifeSciences Corporation Business Overview
9.8.5 Integra LifeSciences Corporation Recent Developments
9.9 B Braun Melsungen AG
9.9.1 B Braun Melsungen AG Hemostats Basic Information
9.9.2 B Braun Melsungen AG Hemostats Product Overview
9.9.3 B Braun Melsungen AG Hemostats Product Market Performance
9.9.4 B Braun Melsungen AG Business Overview
9.9.5 B Braun Melsungen AG Recent Developments
9.10 Gelita Medical GmbH
9.10.1 Gelita Medical GmbH Hemostats Basic Information
9.10.2 Gelita Medical GmbH Hemostats Product Overview
9.10.3 Gelita Medical GmbH Hemostats Product Market Performance
9.10.4 Gelita Medical GmbH Business Overview
9.10.5 Gelita Medical GmbH Recent Developments
9.11 Equimedical
9.11.1 Equimedical Hemostats Basic Information
9.11.2 Equimedical Hemostats Product Overview
9.11.3 Equimedical Hemostats Product Market Performance
9.11.4 Equimedical Business Overview
9.11.5 Equimedical Recent Developments
9.12 Vascular Solutions
9.12.1 Vascular Solutions Hemostats Basic Information
9.12.2 Vascular Solutions Hemostats Product Overview
9.12.3 Vascular Solutions Hemostats Product Market Performance
9.12.4 Vascular Solutions Business Overview
9.12.5 Vascular Solutions Recent Developments
9.13 Marine Polymer Technologies
9.13.1 Marine Polymer Technologies Hemostats Basic Information
9.13.2 Marine Polymer Technologies Hemostats Product Overview
9.13.3 Marine Polymer Technologies Hemostats Product Market Performance
9.13.4 Marine Polymer Technologies Business Overview
9.13.5 Marine Polymer Technologies Recent Developments
9.14 Z-Medica, LLC
9.14.1 Z-Medica, LLC Hemostats Basic Information
9.14.2 Z-Medica, LLC Hemostats Product Overview
9.14.3 Z-Medica, LLC Hemostats Product Market Performance
9.14.4 Z-Medica, LLC Business Overview
9.14.5 Z-Medica, LLC Recent Developments
9.15 CryoLife
9.15.1 CryoLife Hemostats Basic Information
9.15.2 CryoLife Hemostats Product Overview
9.15.3 CryoLife Hemostats Product Market Performance
9.15.4 CryoLife Business Overview
9.15.5 CryoLife Recent Developments
9.16 BioCer Entwicklungs-GmbH.
9.16.1 BioCer Entwicklungs-GmbH. Hemostats Basic Information
9.16.2 BioCer Entwicklungs-GmbH. Hemostats Product Overview
9.16.3 BioCer Entwicklungs-GmbH. Hemostats Product Market Performance
9.16.4 BioCer Entwicklungs-GmbH. Business Overview
9.16.5 BioCer Entwicklungs-GmbH. Recent Developments
9.17 Biom'Up SAS
9.17.1 Biom'Up SAS Hemostats Basic Information
9.17.2 Biom'Up SAS Hemostats Product Overview
9.17.3 Biom'Up SAS Hemostats Product Market Performance
9.17.4 Biom'Up SAS Business Overview
9.17.5 Biom'Up SAS Recent Developments
10 Hemostats Market Forecast by Region
10.1 Global Hemostats Market Size Forecast
10.2 Global Hemostats Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hemostats Market Size Forecast by Country
10.2.3 Asia Pacific Hemostats Market Size Forecast by Region
10.2.4 South America Hemostats Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hemostats by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Hemostats Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Hemostats by Type (2024-2029)
11.1.2 Global Hemostats Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Hemostats by Type (2024-2029)
11.2 Global Hemostats Market Forecast by Application (2024-2029)
11.2.1 Global Hemostats Sales (K Units) Forecast by Application
11.2.2 Global Hemostats Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings